Novartis Contract Manufacturing Capacity Update February 2024: Large Molecule

This presentation from the February 2024 OPCU event provides an overview of the mammalian development services, manufacturing solutions, and Novartis manufacturing sites accessible to external clients. As Novartis expands its mammalian capacity across the manufacturing network, updates on completion dates and capacity availability are presented in the session.

access the Video!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Outsourced Pharma

Novartis Contract Manufacturing